Skip to main content

Corey Kazimov

Analyst

Evercore ISI

Equibles does not estimate personal net worth.

About Corey Kazimov

Corey Kazimov is recorded as Analyst at Evercore ISI. Corey Kazimov has spoken on 7 earnings calls across 5 companies, most recently for BioNTech SE on November 3, 2026. Those appearances were for BioNTech SE (BNTX), BridgeBio Pharma, Inc. (BBIO), Biomarin Pharmaceutical Inc (BMRN), Neurocrine Biosciences Inc (NBIX) and Regeneron Pharmaceuticals, Inc. (REGN). The companies whose calls Corey Kazimov spoke on are classified in the Healthcare sector.

Corey Kazimov on recent calls

“Thanks for taking the question, and congrats once again to Ugar and Oslo, and best of luck with the new endeavor. So on the heels of the encouraging results with PUMI plus LVD at ESMO, what are the next steps for this combination, and what tumor types are you most interested in advancing?”
Analyst — Evercore ISI, 2026 Q3 Earnings Call ·
“I wanted to ask about a Truby's. Obviously, there's been a lot of debate around how to think about quarter over quarter growth. So you put up a sequential increase of $31 million this quarter.”
Analyst — Evercore ISI, BridgeBio Q3 Earnings Call ·
“Perhaps not surprisingly, I also want to ask a question regarding cardio transform, missing the primary endpoint. So, you know, at this point, we obviously know there was substantial background stabilizer use, and putting the silencer on top of it didn't improve outcomes.”
Analyst — Evercore ISI, BridgeBio Q2 Earnings Call ·
“So I also want to ask something on the heels of the competitive update this morning, And I'm wondering how you think about the combination of a weekly CMP analog plus growth hormone eventually slotting into that treatment algorithm.”
Analyst — Evercore ISI, BioMarin Pharmaceutical Second Quarter 2026 Conference Call ·
“I wanted to ask on LVD, the B7H3 ADC candidate, and what data that you've seen that prompted the decision to choose metastatic CRPC as the first indication for phase three development, and kind of what gives you the confidence that you have a competitive ADC construct here?”
Analyst — Evercore ISI, 2026 Q2 Earnings Call ·

Affiliation history

  • Evercore ISI

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity